×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: CBS Microglial Neuroimmune Axis
mechanism
2,847 words
KG: CBS Microglial Neuroimmune Axis
2026-03-29
kind:mechanism
section:mechanisms
state:published
topic:cbs
topic:4r-tauopathies
Contents
CBS Microglial Neuroimmune Axis
⚙
Mechanism Info
Name
CBS Microglial Neuroimmune Axis
Summary
Comprehensive review of microglial activation patterns, neurodegeneration-associated microglia (DAM), TREM2 signaling, neuroimmune crosstalk, and therapeutic targeting in Corticobasal Syndrome
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 0.82
TREM2-mediated microglial tau clearance enhancement
Score: 0.58
Microbial Inflammasome Priming Prevention
Score: 0.65
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.59
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.62
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.63
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.49
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.60
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.46
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.65
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.62
APOE-TREM2 Interaction Modulation
Score: 0.57
Orexin-Microglia Modulation Therapy
Score: 0.56
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.56
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.54
Competitive APOE4 Domain Stabilization Peptides
Score: 0.66
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.49
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.55
TREM2-Dependent Microglial Senescence Transition
Score: 0.83
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.69
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.61
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.58
APOE Isoform Expression Across Glial Subtypes
Score: 0.57
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.56
Microglial Purinergic Reprogramming
Score: 0.55
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.55
APOE Isoform Conversion Therapy
Score: 0.53
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.52
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.52
Show 25 more
Related Analyses (30)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
Show 25 more
Related Experiments (19)
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85
TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
Show 14 more